Previous results from our laboratory demonstrated that overexpressed G6PD was a potential prognostic biomarker in clear cell renal cell carcinoma (ccRCC), the most common subtype of kidney cancer. The gene discussed is G6PD; the disease is nonpapillary renal cell carcinoma.